PHS
MRK icon

PFM Health Sciences’s Merck MRK Stock Holding History

PFM Health Sciences’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-187,834
Closed -$19.8M – 96
2025
Q4 		$19.8M Sell
187,834
-48,634
-21% -$4.57M 1.97% 18
2025
Q3 		$19.8M Buy
+236,468
New +$19.5M 1.53% 19
2024
Q4 		– Sell
-542,811
Closed -$61.6M – 98
2024
Q3 		$61.6M Sell
542,811
-53,450
-9% -$6.35M 3.49% 7
2024
Q2 		$73.8M Hold
596,261
– – 3.65% 5
2024
Q1 		$78.7M Hold
596,261
– – 3.7% 3
2023
Q4 		$65M Hold
596,261
– – 3.9% 3
2023
Q3 		$61.4M Hold
596,261
– – 2.89% 5
2023
Q2 		$68.8M Buy
596,261
+135,143
+29% +$15.3M 2.67% 7
2023
Q1 		$49.1M Buy
461,118
+93,484
+25% +$10.1M 2.17% 12
2022
Q4 		$40.8M Buy
367,634
+7,114
+2% +$727K 1.46% 26
2022
Q3 		$31M Sell
360,520
-611,478
-63% -$54.6M 1.12% 43
2022
Q2 		$88.6M Buy
+971,998
New +$86.2M 3.38% 6
2016
Q4 		– Sell
-495,871
Closed -$29.5M – 111
2016
Q3 		$29.5M Buy
+495,871
New +$29M 0.86% 46
2015
Q1 		– Sell
-745,655
Closed -$40.4M – 94
2014
Q4 		$40.4M Buy
745,655
+546,839
+275% +$30.5M 0.94% 37
2014
Q3 		$11.2M Buy
+198,816
New +$11.2M 0.26% 53
2013
Q4 		– Sell
-408,047
Closed -$18.5M – 69
2013
Q3 		$18.5M Buy
408,047
+360,613
+760% +$16.5M 0.45% 46
2013
Q2 		$2.1M Buy
+47,434
New +$2.12M 0.04% 70

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's MRK Position: Q1 2026 in Review

PFM Health Sciences sold out of Merck (MRK) in Q1 2026, closing a stake of 187,834 shares — an estimated $19.8M sold.

PFM Health Sciences first reported a position in MRK in Q2 2013 and held it in 17 quarters. The position peaked at $88.6M in Q2 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PFM Health Sciences reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • PFM Health Sciences sold 187,834 Merck shares in Q1 2026, an estimated $19.8M.
  • PFM Health Sciences first reported a position in Merck in Q2 2013 and held it in 17 quarters.
  • PFM Health Sciences's Merck position peaked at $88.6M in Q2 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.